Note: Ingredients listed on restricted chemical lists
EC/CAS
556-52-5
Name of the chemical
2,3-Epoxy-1-propanol R-2,3-Epoxy-1-propanol
Concentration
0.1-1.0
EC/CAS
106-89-8
Name of the chemical
1-Chlor-2,3-epoxypropan
Concentration
0.1-1.0
General Information
Revision date
2011-02-18
Product name
HELOXY Modifier 71
supplier name
Momentive Specialty Chemicals Inc
Emergency telephone
1-866-303-6949, (800) 424-9300, (703) 527-3887, 1 888 443 9466
Icons in SDS
Company Information
company name
Momentive Specialty Chemicals Inc
e-mail address of the competent person responsible for the Safety Data Sheet
4information@momentive.com
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) Form Viscous liquid. OSHA/HCS status This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Emergency overview WARNING ! MAY CAUSE ALLERGIC RESPIRATORY AND SKIN REACTION. MAY CAUSE RESPIRATORY TRACT, EYE AND SKIN IRRITATION.
Potential Acute Health Effects
Inhalation Slightly irritating to the respiratory system. May cause sensitization by inhalation. Ingestion Not expected to be harmful under normal conditions of use. Skin Slightly irritating to the skin. May cause sensitization by skin contact. Eyes Slightly irritating to the eyes.
Potential chronic health
effects Contains material that may cause target organ damage, based on animal data. Carcinogenicity Contains material which may cause cancer. Risk of cancer depends on duration and level of exposure. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which causes damage to the following organs: lungs, Review Section 2 and 11 for any additional assessments. Over-exposure signs/symptoms Inhalation Adverse symptoms may include the following: respiratory tract irritation, coughing, wheezing and breathing difficulties, asthma, Ingestion No specific data. Skin Adverse symptoms may include the following: irritation, redness, Eyes Adverse symptoms may include the following: irritation, watering, redness,
Medical Conditions Generally Aggravated by Exposure
Pre-existing respiratory and skin disorders and disorders involving any by over-exposure other target organs mentioned in this MSDS as being at risk may be aggravated by over-exposure to this product. See section 11 for more detailed information on health effects and symptoms.
